Zoster Vaccine Recombinant, Adjuvanted

Preferred Label : Zoster Vaccine Recombinant, Adjuvanted;

NCIt synonyms : HZ/su Vaccine GSK 1437173A; Herpes Zoster Subunit Vaccine GSK 1437173A; Herpes Zoster Vaccine 1437173A;

NCIt related terms : RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN;

NCIt definition : A recombinant, subunit herpes zoster (HZ) vaccine containing varicella-zoster virus (VZV) glycoprotein E (gE), that can potentially be used to prevent HZ infection, also called shingles. Upon administration, zoster vaccine recombinant, adjuvanted stimulates the host immune system to induce both specific CD4-positive T-cells and antibodies against VZV gE, thereby protecting against infection with HZ. VZV gE, the most common antigen in VZV viral particles, plays a key role in VZV infection. Compared to live-attenuated vaccines, the subunit vaccine prevents the risk of vaccine-induced HZ in immunocompromised patients.;

UNII : COB9FF6I46;

Drug name : Shingrix;

Molecule name : 1437173A; GSK1437173A; GSK 1437173A;

NCI Metathesaurus CUI : CL413537;

Details

Origin ID

C88288;

UMLS CUI

C4764313;

Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients